Vernalis Group Archive

Select a Month:
Select a Year:
Search for:
Run your search


Date Title
04/09/2003 Vernalis Group plc (VER) directorate change
05/06/2003 Vernalis to take back A2A antagonist depression rights from Roche
28/05/2003 Results of Extraordinary General Meeting
27/05/2003 Results of Placing and Open Offer
01/05/2003 Vernalis Group plc proposed Placing and Open Offer to raise £16 million
07/04/2003 Vernalis announces UK launch of frovatriptan
02/04/2003 Vernalis confirms frovatriptan highly effective in preventing menstrual migraine
21/03/2003 Vernalis Group plc: preliminary results for the year ended 31 December 2002